CD8+ T cell priming by dendritic cell vaccines requires antigen transfer to endogenous antigen presenting cells.
Immunotherapeutic strategies to stimulate anti-tumor immunity are promising approaches for cancer treatment. A major barrier to their success is the immunosuppressive microenvironment of tumors, which inhibits the functions of endogenous dendritic cells (DCs) that are necessary for the generation of...
Main Authors: | Alice W Yewdall, Scott B Drutman, Felecia Jinwala, Keith S Bahjat, Nina Bhardwaj |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-06-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2886840?pdf=render |
Similar Items
-
CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens.
by: Salio, M, et al.
Published: (2004) -
Vaccination of Diffuse Large B- Cell Lymphoma Patients with Antigen-Primed Dendritic Cells
by: Masoud Bahrami, et al.
Published: (2013-05-01) -
Exploiting the role of endogenous lymphoid-resident dendritic cells in the priming of NKT cells and CD8+ T cells to dendritic cell-based vaccines.
by: Troels R Petersen, et al.
Published: (2011-03-01) -
A-kinase anchoring in dendritic cells is required for antigen presentation.
by: Robynn V Schillace, et al.
Published: (2009-01-01) -
Mature dendritic cells differentiated in the presence of interferon-beta and interleukin-3 prime functional antigen-specific CD8 T cells.
by: Renneson, J, et al.
Published: (2005)